scispace - formally typeset
J

Jeremy Nel

Researcher at University of the Witwatersrand

Publications -  42
Citations -  3196

Jeremy Nel is an academic researcher from University of the Witwatersrand. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 11, co-authored 33 publications receiving 1636 citations. Previous affiliations of Jeremy Nel include University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

Hongchao Pan, +73 more
TL;DR: These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initiation of ventilation, and duration of hospital stay.
Posted ContentDOI

Repurposed antiviral drugs for COVID-19: interim WHO solidarity trial results (Preprint)

Pan Hongchao, +74 more
- 15 Oct 2020 - 
TL;DR: These Remdesivir, Hydroxychloroquine, Lopinavir and Interferon regimens appeared to have little or no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation and duration of hospital stay.
Journal ArticleDOI

Adult antiretroviral therapy guidelines 2017

TL;DR: These guidelines are intended as an update to those published in the Southern African Journal of HIV Medicine in 2014 and the update on when to initiate antiretroviral therapy in 2015.
Journal ArticleDOI

Long-COVID: An evolving problem with an extensive impact

TL;DR: Persistence of symptoms or development of new symptoms relating to SARS-CoV-2 infection late in the course of COVID-19 is an increasingly recognised problem facing the globally infected population and its health systems.
Journal ArticleDOI

Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study.

Waasila Jassat, +1546 more
TL;DR: In this paper, the authors analyzed data from the DATCOV national active surveillance system for COVID-19 admissions to hospital from March 5, 2020, to March 27, 2021.